secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quantum-Si Inc (QSI)
CIK:        0001816431
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001816431-26-000032
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quantum-Si Q1 net loss widens to $21.7M; Proteus sequencing milestones on track
-------------------------------------------------------------------------------

- Revenue of $258,000, gross margin 29%; net loss $21.7M vs $19.2M YoY.
- Adjusted EBITDA negative $20.1M; adjusted operating expenses $21.4M.
- Achieved automated sequencing runs on integrated Proteus instruments.
- Current kit detects 17 amino acids; first customer samples sequenced on prototype.
- Anticipates commercial launch end of 2026; early access sites this summer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816431/000181643126000032/0001816431-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816431/000181643126000032/qsi-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001816431-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer